Intensity Therapeutics (INTS) Stock Price, Quote, News & History

Comments

Intensity Therapeutics Inc (INTS) Stock Price, Quote, News & History

INTSNASDAQ

Trade with Public

$7.72

0.020.26%

At close: Mar 5, 4:00 PM EST

$7.76

0.04340.56%

After Hours: 7:59 PM EST

OverviewNews Earnings Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$7.64

Close

$7.72

Volume / Avg.

19.82K / 86.73K

Day Range

$7.49 - $7.78

52 Wk Range

4.63 - 62.49

Market Cap

$19.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

43.98%

Days to Cover

1

Recent Intensity Therapeutics Inc News

What's Going On With Intensity Therapeutics Stock Friday?

Intensity Therapeutics slid Friday after announcing a 1-for-25 reverse split effective Feb. 18 to regain Nasdaq bid-price compliance.

Nabaparna Bhattacharya

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results

Avi Kapoor

Nasdaq Surges Over 1%; Apple Earnings Top Views

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.50M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

13.79M

Free Cash Flow (TTM)

-9.50M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

4.29M

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$12.33M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.70

Earnings Yield % (TTM)

-178.57%

Earnings Yield % (FWD)

-74.68%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.85

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$7.07M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$7.64

Close

$7.72

Volume / Avg.

19.82K / 86.73K

Day Range

$7.49 - $7.78

52 Wk Range

4.63 - 62.49

Market Cap

$19.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

43.98%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, followin...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Intensity Therapeutics (INTS) stock?

A

You can purchase shares of Intensity Therapeutics (NASDAQ:INTS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Intensity Therapeutics (INTS) competitors?

A

Other companies in Intensity Therapeutics’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX), Curis Inc (NASDAQ:CRIS) and Nanoviricides Inc (AMEX:NNVC).

Q

What is the forecast, or price target, for Intensity Therapeutics (INTS) stock?

A

Intensity Therapeutics has a consensus price target of $4.50.

Q

What is the current price for Intensity Therapeutics (INTS)?

A

The stock price for Intensity Therapeutics (NASDAQ: INTS) is $7.7634 last updated March 5, 2026 at 7:59 PM EST.

Q

Does Intensity Therapeutics (INTS) pay a dividend?

A

There are no upcoming dividends for Intensity Therapeutics.

Q

When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?

A

Intensity Therapeutics does not have any upcoming earnings scheduled.

Q

Is Intensity Therapeutics (INTS) going to split?

A

There is no upcoming split for Intensity Therapeutics.

Q

What sector and industry does Intensity Therapeutics (INTS) operate in?

A

Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Serina Therapeutics Inc

Quoin Pharmaceuticals Ltd

NNVC

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.59

-1.52%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.62

0.93%

Apimeds Pharmaceuticals Us Inc

AMEX:APUS

$1.30

-2.26%

Key Statistics

Open

$7.64

Close

$7.72

Volume / Avg.

19.82K / 86.73K

Day Range

$7.49 - $7.78

52 Wk Range

4.63 - 62.49

Market Cap

$19.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

43.98%

Days to Cover

1

Recent Intensity Therapeutics Inc News

What's Going On With Intensity Therapeutics Stock Friday?

Intensity Therapeutics slid Friday after announcing a 1-for-25 reverse split effective Feb. 18 to regain Nasdaq bid-price compliance.

Nabaparna Bhattacharya

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results

Avi Kapoor

Nasdaq Surges Over 1%; Apple Earnings Top Views

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.50M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

13.79M

Free Cash Flow (TTM)

-9.50M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

4.29M

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$12.33M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.70

Earnings Yield % (TTM)

-178.57%

Earnings Yield % (FWD)

-74.68%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.85

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$7.07M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$7.64

Close

$7.72

Volume / Avg.

19.82K / 86.73K

Day Range

$7.49 - $7.78

52 Wk Range

4.63 - 62.49

Market Cap

$19.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

43.98%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, followin...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry